I have tried to find comparable examples, but with little success. Best I could find was a company being taken over primarily for 1 drug that was seen as a possible block buster.
It was very late in the trial process, so it had been as about as de-risked as you could hope for [Refer RA's comments about waiting] and the price paid was 3 times the estimated revenue that would be generated. The IPO in 2009 was around $150 million US dollars, Not sure how much patent time was left.
So Monepantel as a drug could make the owner ??? Patents start to expire starting 2032 for Canine/Human cancer and 2040 for antiviral. So a reasonably long runway for a company to get their money back.
Remember RA has said he thinks 1 company will take all the licenses. Not sure if he was including the Doggies in that.
Does anyone have any evidence of similar situations ?
Pete
Ann: AGM Presentation, page-63
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.015(8.11%) |
Mkt cap ! $89.00M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 20.5¢ | 18.8¢ | $311.3K | 1.576M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 388155 | 1 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |